Period Ending | Sep 2, 2011 | Jun 3, 2011 | Mar 4, 2011 | Dec 3, 2010 |
---|
Total Revenue
|
1,013,212
|
1,023,179
|
1,027,706
|
1,007,946
| Cost of Revenue | 104,654 | 109,201 | 107,639 | 107,217 | |
Gross Profit
|
908,558
|
913,978
|
920,067
|
900,729
| |
|
Operating Expenses |
|
Research Development | 181,039 | 183,211 | 178,400 | 170,378 |
|
Selling General and Administrative | 439,217 | 444,237 | 429,057 | 423,031 |
|
Non Recurring | 3,816 | (586) | 41 | 2,193 |
|
Others | 10,376 | 10,392 | 10,235 | 18,184 |
|
|
|
Total Operating Expenses | 634,448 | 637,254 | 617,733 | 613,786 | | |
Operating Income or Loss
|
274,110
|
276,724
|
302,334
|
286,943
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (960) | (753) | 773 | 15,854 |
|
Earnings Before Interest And Taxes | 273,150 | 275,971 | 303,107 | 302,797 |
|
Interest Expense | 16,431 | 16,727 | 17,020 | 16,786 |
|
Income Before Tax | 256,719 | 259,244 | 286,087 | 286,011 |
|
Income Tax Expense | 61,618 | 29,808 | 51,496 | 17,161 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 195,101 | 229,436 | 234,591 | 268,850 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
195,101
|
229,436
|
234,591
|
268,850
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
195,101
|
229,436
|
234,591
|
268,850
|
|